Pemetrexed disodium hemipentahydrate

Pemetrexed disodium hemipentahydrate Basic information
Product Name:Pemetrexed disodium hemipentahydrate
Synonyms:N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate;PeMetrexed sodiuM hydrate (1:2:2.5);Pemetrexed disodium hydrate;PeMetrexed DisodiuM heMipenta hydrate;Pemetrexed disodium 2.5 hydrate;PeMetrexed (disodiuM heMipenta hydrate) (1:2:2.5);L-GlutaMic acid,N-[4-[2-(2-aMino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoyl]-,sodiuM salt, hydrate (2:4:5) (9CI);LY-231514 Disodium Hydrate
CAS:357166-30-4
MF:C20H24N5NaO7
MW:469.43
EINECS:814-356-7
Product Categories:Inhibitors;Anti-cancer&immunity;API;357166-30-4
Mol File:357166-30-4.mol
Pemetrexed disodium hemipentahydrate Structure
Pemetrexed disodium hemipentahydrate Chemical Properties
Melting point 274-276°C (dec.)
storage temp. Room Temperature
solubility DMSO, Methanol, Water
form Solid
color Off-White
CAS DataBase Reference357166-30-4(CAS DataBase Reference)
Safety Information
MSDS Information
Pemetrexed disodium hemipentahydrate Usage And Synthesis
UsesPemetrexed Disodium Hydrate is an chemotherapy drug for the treatment of pleural mesothelioma and non-small cell lung cancer. Pemetrexed Disodium Hydrate exhibit inhibitory activities towards thymidyl ate synthase as well as other folate dependent enzymes.
UsesPemetrexed Disodium Hydrate is an chemotherapy drug for the treatment of pleural mesothelioma and non-small cell lung cancer. Pemetrexed Disodium Hydrate exhibit inhibitory activities towards thymidylate synthase as well as other folate dependent enzymes.
Pemetrexed disodium hemipentahydrate Preparation Products And Raw materials
4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid Pemetrexed Disodium N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid disodium salt hydrate Pemetrexed

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.